People's Hospital of Ningxia Hui Autonomous Region
9
4
4
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
China Axial Length Study
Role: collaborator
Assessing the Effectiveness of Continuous Glucose Monitoring in Enhancing Surgical Outcomes for Patients with Diabetes
Role: collaborator
Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing
Role: collaborator
Evaluation of the Castor Single Branch Stent Graft in Treatment of Acute Aortic Syndrome
Role: collaborator
Endoscopic Ruler for the Assessment of Variceal Bleeding Risks (CHESS2005)
Role: collaborator
Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)
Role: collaborator
Baseline Investigation of Patients With Cardiac Arrest in China
Role: collaborator
Stroke Imaging Package Study of Intracranial Atherosclerosis ( SIPS-ICAS )
Role: collaborator
Chinese Chronic Renal Insufficiency Study: Based on Smartphone Platform
Role: collaborator
All 9 trials loaded